Rohini Sandesara

Rohini Sandesara has a diverse work experience in the field of scientific research and development. Rohini is currently a Senior Scientist at Bavarian Nordic, a role they started in May 2023. Prior to that, they worked at Emergent BioSolutions as a Senior Scientist from April 2022 to May 2023, and as a Scientist from March 2021 to April 2022.

Before joining Emergent BioSolutions, Rohini worked at Q² Solutions, where they held multiple roles. Rohini was an R&D Senior Scientist, focusing on vaccines, from April 2018 to March 2021. Prior to that, they were a R&D Scientist II, also in the vaccines division, from April 2017 to April 2018. Rohini started their tenure at Q² Solutions in September 2014 as an R&D Scientist in the vaccines division, a position they held until April 2017.

Rohini's work experience also includes a role as an APHL Emerging Infectious Disease Training Fellow at the Centers for Disease Control and Prevention from September 2013 to August 2014. During this fellowship, they worked in the Molecular Diagnostics and Research Laboratory in the Dengue Branch, focusing on characterizing the serotypes of the dengue virus.

Earlier in their career, Rohini worked as a Research Technician at Albert Einstein College of Medicine from May 2007 to November 2012. Rohini'swork there involved studying Filoviruses and their glycoproteins, purifying and characterizing the GP ectodomain of Ebolavirus, and collaborating on projects related to viral infection and antibody characterization.

Overall, Rohini Sandesara has extensive experience in scientific research, with a focus on vaccines, infectious diseases, and viral characterization.

Rohini Sandesara pursued their Bachelor of Science (BS) degree in Biology, General from Duquesne University. Rohini attended the university from 2002 to 2004.